PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 17989720-1 2008 We investigated the hypothesis that gemtuzumab ozogamicin (GO), an anti-CD33 immunotoxin would improve the efficacy of fludarabine/melphalan as a preparative regimen for allogeneic hematopoietic stem cell transplantation (HSCT) in a phase I/II trial. fludarabine 119-130 CD33 molecule Homo sapiens 72-76 22584460-0 2013 Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. fludarabine 132-143 CD33 molecule Homo sapiens 55-59 9688287-8 1998 Three-colour fluorescence analysis demonstrated a differentiation pattern of CD34+ cells, with a greater expression of CD13 and CD33 after treatment with fludarabine compared to untreated patients and normal controls. fludarabine 154-165 CD33 molecule Homo sapiens 128-132